chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient has no significant medial problems. He received 1st dose of vaccine on 5/19/21. Since 6/2/21 noted bruises, on 6/7/21 came to ED and fount to have platelets 5000/ul. He received 3 units of platelets, IVIG  and started treatment with dexamethasone
1325 Pt sitting in chair in OBS.  Pt appeared slightly vague and hands shaking.  Pt did grasp bottle of water when given. Pt unable to open water bottle and increase hand trembling noted.  Pt began leaning forward.  Pt did not respond when asked name or if she needed help opening water bottle.  Pt became unresponsive and slouched forward with left UE contracted and gerbilled words unable to identify.  EMS activated.  Pt eased to floor without complications with EMS asst.  Pt aroused after appx 10-15 sec with verbal cuing.  Pt alert and oriented, unable to remember all details, diaphoretic. Pt asst to med eval room via WC.  Within 2 minutes of obtaining pt demo and info, pt displayed another episode as previous:  unresponsive, left UE contractured and diaphoretic.  EMS assessed eyes/pupils-fixed and non-reactive.  Pt arouse again with vague and confusion. Pt denies hx of SZ or TIA.  No loss of bowel or bladder.  Reports dizzy and confused.  IV started to left posterior wrist by EMS and EKG complete-SR.  TC to pt daughter information given.  Pt to be transferred to medical center.  Pt A&O.  Pt transferred to stretcher with asst. and HOB elevated. Pt with personal belongings and reassured to return in 3 weeks for 2nd dose of vaccine.
expired booster dose of Moderna vaccine; vial was in the refrigerator; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired booster dose of Moderna vaccine) and PRODUCT STORAGE ERROR (vial was in the refrigerator) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired booster dose of Moderna vaccine) and PRODUCT STORAGE ERROR (vial was in the refrigerator). On 28-Oct-2021, EXPIRED PRODUCT ADMINISTERED (expired booster dose of Moderna vaccine) and PRODUCT STORAGE ERROR (vial was in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The vial was in the refrigerator and had been compromised with no temperature excursion.  No concomitant medication were provided. Treatment information was not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2021: Follow-up received on 02-NOV-2021 contains ADR form added with HCP and race information added.
Patient had generalized anxiety disorder. Onsite EMS was called vitals BP 129/76 BG  99% O2 HR 80. Patient refunded evaluation or care and released against medical advise.
Ill; This case was reported by a consumer via  interactive digital media and described the occurrence of unwell in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced unwell. On an unknown date, the outcome of the unwell was unknown.   It was unknown if the reporter considered the unwell to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the reporter whom he/she knew. The age at vaccination was not reported. The reporter stated that shot could make you feel like you were dying. The reporter stated that he/she knew patient who got Shingles vaccine and got extremely ill. The case was linked with US2021AMR186615 reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR186615:same reporter
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown.            No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.  Very limited information regarding this event has been provided at this time.  Further information has been requested.
19 year old patient received an adult dose of Engerix-B; 19 year old patient received an adult dose of Engerix-B; This case was reported by a other health professional via call center representative and described the occurrence of adult product administered to child in a 19-year-old female patient who received HBV (Engerix B adult) (batch number N4GA4, expiry date 2nd January 2023) for prophylaxis.   Previously administered products included Engerix B (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Engerix B adult. On an unknown date, unknown after receiving Engerix B adult, the patient experienced adult product administered to child and overdose. On an unknown date, the outcome of the adult product administered to child and overdose were unknown.  Additional details were provided are as follows: A 19 years old patient received an adult dose of Engerix B in her series which led to adult product administered to child and overdose. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up via email.
BOTH HANDS WERE SWOLLEN; FINGERS WERE SORE LIKE ARTHRITIS BUT IT WAS NOT ARTHRITIS; TINGLING IN BOTH HANDS; HANDS FELL ASLEEP; This spontaneous report received from a patient concerned a 74 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 23-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 26-MAY-2021, the patient experienced both hands were swollen, fingers were sore like arthritis but it was not arthritis, tingling in both hands, and hands fell asleep. Laboratory data (dates unspecified) included: X-ray (NR: not provided) shown to be fine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from both hands were swollen, and tingling in both hands, and the outcome of hands fell asleep and fingers were sore like arthritis but it was not arthritis was not reported. This report was non-serious.
Minor to moderate chest pain on left side of chest in the heart area. Only noticeable on certain arm movements and some deep breaths.
Patient said he had pain in the arm and trouble moving his arm later in the day after the flu shot. Can't sleep on his side.
Adverse event: Fever, headache, naucious , diarrhea, chest pain, chills, swelling and pain in chest and left arm., infection. Patient was intubated  Treatment: Steroids, Antibiotics and surgery. Outcome: still pending and under treatment in hospital.
Patient was given Pfizer 2nd dose vaccine in left arm at 1324 and after that patient verbalized she was feeling dizzy.  patient decided to lay back. At 1326 I examined the patient. Patient appeared sweaty, weak, and appeared to be having a vasovagal response. Patient was awake, alert and oriented x3 at all times. EMS examined vital signs: 81/47 pulse-63, O2-99%. Patient recommended to go to ER for further evaluation, but patient refused. Refusal form signed by patient. Patient refused for her fiance to drive in her stead. Patient left facility at 1409 in no acute distress.
A report was received from a health care professional on 10/26/01 regarding a 80 year old female patient who developed a rash 24 hours following the administration of Fluvirin vaccine (batch E4254BB) on 12/01/94. Rash was described as red, pitted, lumpy over arm and chest. The patient was treated with cortisone cream administered by the casualty department. The event resolved approximately 6 days later. There was insufficient information to determine the  reporter's causality assessment.
Information has been received from a consumer concerning the 15 year old daughter of her friend who "months an months ago" was vaccinated with GARDASIL (route and site not reported). Subsequently the patient experienced vomiting, seizures, shakes, black out, abdominal pain and excruciating pain from head to toe and was hospitalized in and out. Per caller, the last time she spoke to the patient's parents, the patient was at home but they are thinking of bringing the patient to another hospital. Per caller, the patient's vomiting, seizures, shakes, black out, abdominal pain and excruciating pain from head to toe persisted. Attempts to verify the existence of an identifiable patient have been unsuccessful. No further information is available.
All the symptoms of myocarditis which is chest pain, breathing difficulties, and feelings of fast beating, shaking of body and pounding heart. Almost every other day
Vaccine was placed in the fridge on 12/1/21 and administered 1/6/22.
7MAY92 330PM mom called clinic to report pt had redness & swelling of both upper thighs & running a temp (but did not take temp); by evening 7MAY92 p/APAP pt was better; 9MAY92 swelling gone;
2/26/2023 I started with a sore throat, a little cough, and a little runny nose.  2/27 At Home COVID-19 Test positive.   Televisit with doctor who proscribed Paxlovid.  Started Paxlovid on 2/28. Symptoms diminished while on Paxlovid to the point that on 3/3/23 symptoms were gone.
patient was fine after receiving the flu shot at 0930am, approximately 30 mins after receiving the shot, patient complained about losing color vision, "everything looks black and white", then patient started getting tremors shortly after. our pulse oximeter showed over 200 for HR. immediately called EMS. injected Adult epipen on L thigh then EMS showed up shortly after, then patient was transported to ER.
Chills; Fever 101 F; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and PYREXIA (Fever 101 F) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced CHILLS (Chills) and PYREXIA (Fever 101 F). On 14-Mar-2021, CHILLS (Chills) and PYREXIA (Fever 101 F) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product information was reported.   No treatment information was reported.
Red area below the injection site that goes almost to her elbow; Feels chilly; Extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red area below the injection site that goes almost to her elbow), FATIGUE (Extremely tired) and CHILLS (Feels chilly) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced FATIGUE (Extremely tired). On 19-Mar-2021, the patient experienced ERYTHEMA (Red area below the injection site that goes almost to her elbow) and CHILLS (Feels chilly). On 18-Mar-2021, FATIGUE (Extremely tired) had resolved. At the time of the report, ERYTHEMA (Red area below the injection site that goes almost to her elbow) and CHILLS (Feels chilly) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable  No concomitant medications were reported Patient used ice on erythema site and it helped   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Additional document contains no new information
Pt recd the 2nd dose after 21 days of 1st dose 3 days prior to the minimal days interval. No adverse effect noted.
On 3/3 I had extreme fatigue until 3/5.  On the same day, 3/5, swelling, itching and redness at the injection site then started.  Starting on the next day, 3/6, additional symptoms included extremely itchy bumps down the left arm, the right arm and both legs (mainly the thighs).
Fever for one week, 103 degrees on day 4, fever blister on face, still resent. Now gone.
Headache; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 032B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 27-Feb-2021, the patient experienced HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) and HEADACHE (Headache) outcome was unknown.            Concomitant product use was not provided by the reporter.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-072932 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-072932:second dose
Numbness; pain; difficulty walking; This is a spontaneous report from a contactable consumer or other non-Health Care Professional (patient). A 74-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6202 and Expiry date: Unknown) via an unspecified route of administration, administered in Arm Left on 27Feb2021 12:00 as DOSE 1, SINGLE for covid-19 immunization. Medical history included myasthenia gravis, small fibre neuropathy, Sjogren's syndrome, orthostatic hypertension. The patient previously took cipro [ciprofloxacin hydrochloride] and experienced drug hypersensitivity. Concomitant medication(s) included hydroxychloroquine sulfate (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), pyridostigmine bromide (MESTINON), droxidopa (NORTHERA), Vitamin D Nos taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient was not diagnosed with Covid 19 and has not been tested for Covid-19 Since the vaccination. On 27Feb2021 12:15 the patient experienced numbness, pain, and difficulty walking shortly after vaccine. Reported to attendant. Was told to contact Primary care if didn't improve. I have not done so. The symptoms continued to increase for 3 days and then began subsiding. Walking has returned to normal, but still some residual pain and numbness. The patient did not have covid prior vaccination and was not tested post vaccination. The patient did not receive any treatment for the events. The outcome of events was recovering.   No follow-up attempts are possible. No further information is expected.
Patient sustained miscarriage. G1P0,  Due Date 11/1/2021
Daughter received vaccine. Got up from medical table and was standing against wall. Received instructions from MA following injection and daughter was fine. MA left room to get final paperwork together following physician appointment. Daughter stated 'I feel weird'. She then fell to ground. She did not attempt to catch herself during fall. Her upper extremities were tonic, muscles tight, and her head began jolting. Her teeth were clenched, and she was making a humming/moaning sound. She was unresponsive and did not respond to verbal or tactile stimulus. This lasted for at least 30 seconds.
lower arm shooting pain in the side that was injected. nerve type shooting pain from the elbow to the wrist, pain mostly in the thumb
Four months post vax, this child developed thrombocytopecia and was hospitalized for one day to receive IG. The reporting physician felt that the thrombocytopecia may have been related to therapy with vax.
Pt developed significant hives throughout his body, most concentrated on his back and abdomen. The child was very itchy and expressed how uncomfortable he felt.  The hives lasted approximately 3-4 days and improved gradually after baths in oatmeal and berries.
felt very weak; tired; couldn't keep food down, vomiting even after water; diarrhea; night sweats; runny nose; COVID-19 antibody test negative; lost 20 pounds; felt ill; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as "age: 69; unit: unknown") received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 12Feb2021 (batch/lot number was not reported) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose on 12Feb2021 and felt ill for 3 weeks later (Mar2021). She felt very weak and tired on unspecified date. She couldn't keep food down, vomiting even after water. She had diarrhea, night sweats and had to change her clothes and sheets. She has lost 20 pounds and experienced a runny nose. She is finally getting some energy back. She went to receive her second dose of the vaccine, but the clinic told her to get an antibody test.  Her antibody test came back negative. The patient was recovering from being tired; outcome of the rest of the events was unknown.  Information on the lot/batch number has been requested.
About 24 hrs p/vax pt relates rash in lt deltoid area, inspiratory chest pain, shooting pain in both upper arms by flushing; rash became pruritic; seen in ER 16MAY92 given DPH;
Information has been received on 16-JAN-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 15-FEB-2016, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) subcutaneous, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 30-JUN-2016, the patient was treated by a physician for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient has been prescribed VALTREX for management of her painful condition. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Two days after I got my first dose on 3/12/2021, I was eating dinner at about 6:30PM. My tongue felt swollen. When I ate, I had an intense burning sensation. The food wasn't spicy, but it was salty. I realized something was wrong, but I figured it was temporary; unfortunately, it has persisted and I still have it. I did research, and the description of burning mouth syndrome fits it.  On 5/30/2021 at around 9:30AM, I was lying in bed and I felt really itchy, and it woke me up. I was also sweating and felt feverish. (This was over a month after my second vaccination.) I scratched my arm a little, but I didn't think much of it. When I got up at 11AM and went to the bathroom, I saw that both my arms were covered with rashes from the elbow down. As the day progressed, the itching was so intense, and I had a fever of 100. I took Benadryl and rubbed hydrocortisone cream all over my arms, but this helped very little. I then developed chicken pox-like blisters between my fingers, which popped on their own and oozed. The breakouts on my arms took different forms and included petichiae, blood blisters, and measles-like sores. The following day, I felt my ears get hot and itchy, and then the breakout spread all over my face; my cheeks were covered in welts. I finally got to see the doctor on 6/8/2021, but I got no diagnosis, since they didn't know if my symptoms were caused by long COVID or by the vaccine.  They gave me hydroxizine, Chipro, and a shot of dexamethazone. I was advised to take ibuprofen for general pain relief and given betamethazone cream. None of the medications were at all effective. The symptoms then got much worse; the breakout spread all over my body and my skin felt like it was on fire! My skin was so hypersensitive that I couldn't bear to wear clothes or even pet my cat! I also had to keep my thermostat at 68 degrees. I currently have boils all over my face and scalp and boils. I am currently on doxycycline, famotidine, ceterizine, gentamicin cream, and ibuprofen.
Narrative: Patient received 2nd Pfizer shot today. Reported discomfort to injection site. Patient was not in acute distress.
sometimes loses her memory; This is a spontaneous report received from a non-contactable consumer (patient). This female patient of unspecified age received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 27Feb2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient sometimes lost her memory. The patient wanted information on how to receive the second dose of BNT162B2. She received dose 1 on the 27th day a month ago (27Feb2021). During the call she stated she sometimes lost her memory. The outcome of sometimes lost her memory was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.